Literature DB >> 27646567

Progression and Transmission of HIV/AIDS (PATH 2.0).

Chaitra Gopalappa1, Paul G Farnham2, Yao-Hsuan Chen2, Stephanie L Sansom2.   

Abstract

BACKGROUND: HIV transmission is the result of complex dynamics in the risk behaviors, partnership choices, disease stage and position along the HIV care continuum-individual characteristics that themselves can change over time. Capturing these dynamics and simulating transmissions to understand the chief sources of transmission remain important for prevention.
METHODS: The Progression and Transmission of HIV/AIDS (PATH 2.0) is an agent-based model of a sample of 10,000 people living with HIV (PLWH), who represent all men who have sex with men (MSM) and heterosexuals living with HIV in the U.S.A. Persons uninfected were modeled as populations, stratified by risk and gender. The model included detailed individual-level data from several large national surveillance databases. The outcomes focused on average annual transmission rates from 2008 through 2011 by disease stage, HIV care continuum, and sexual risk group.
RESULTS: The relative risk of transmission of those in the acute phase was nine-times [5th and 95th percentile simulation interval (SI): 7, 12] that of those in the non-acute phase, although, on average, those with acute infections comprised 1% of all PLWH. The relative risk of transmission was 24- to 50-times as high for those in the non-acute phase who had not achieved viral load suppression as compared with those who had. The relative risk of transmission among MSM was 3.2-times [SI: 2.7, 4.0] that of heterosexuals. Men who have sex with men and women generated 46% of sexually acquired transmissions among heterosexuals.
CONCLUSIONS: The model results support a continued focus on early diagnosis, treatment and adherence to ART, with an emphasis on prevention efforts for MSM, a subgroup of whom appear to play a role in transmission to heterosexuals.

Entities:  

Keywords:  Decision Analysis; HIV AND AIDS; Risk Communication or Risk Perception; Simulation Methods (Monte Carlo Methods; simulation; etc)

Mesh:

Year:  2016        PMID: 27646567     DOI: 10.1177/0272989X16668509

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  25 in total

1.  Pharmacy Data as an Alternative Data Source for Implementation of a Data to Care Strategy.

Authors:  Kathy K Byrd; Nasima M Camp; Kashif Iqbal; Paul J Weidle
Journal:  J Acquir Immune Defic Syndr       Date:  2019-09-01       Impact factor: 3.731

2.  Missed Opportunities for HIV Testing Among STD Clinic Patients.

Authors:  Sharleen M Traynor; Lisa Rosen-Metsch; Daniel J Feaster
Journal:  J Community Health       Date:  2018-12

3.  Sex Practices by HIV Awareness and Engagement in the Continuum of Care Among MSM: A National HIV Behavioral Surveillance Analysis in 21 U.S. Cities.

Authors:  Hilary K Whitham; Stephanie L Sansom; Cyprian Wejnert; Teresa Finlayson; Ya-Lin A Huang; Qian An; Gabriela Paz-Bailey
Journal:  AIDS Behav       Date:  2018-03

4.  A religiously-tailored, multilevel intervention in African American churches to increase HIV testing: Rationale and design of the Taking It to the Pews cluster randomized trial.

Authors:  J Berkley-Patton; C Bowe Thompson; K Goggin; D Catley; M Berman; A Bradley-Ewing; K P Derose; K Resnicow; J Allsworth; S Simon
Journal:  Contemp Clin Trials       Date:  2019-09-16       Impact factor: 2.226

5.  Self-efficacy and HIV testing among Latino emerging adults: examining the moderating effects of distress tolerance and sexual risk behaviors.

Authors:  Daisy Ramírez-Ortiz; Diana M Sheehan; Gladys E Ibañez; Boubakari Ibrahimou; Mario De La Rosa; Miguel Ángel Cano
Journal:  AIDS Care       Date:  2020-03-04

6.  Trends in HIV Testing Among US Adults, Aged 18-64 Years, 2011-2017.

Authors:  Deesha Patel; Christopher H Johnson; Amy Krueger; Barbara Maciak; Lisa Belcher; Norma Harris; Elizabeth A DiNenno
Journal:  AIDS Behav       Date:  2020-02

7.  Evidence of an Association of Increases in Pre-exposure Prophylaxis Coverage With Decreases in Human Immunodeficiency Virus Diagnosis Rates in the United States, 2012-2016.

Authors:  Dawn K Smith; Patrick S Sullivan; Betsy Cadwell; Lance A Waller; Azfar Siddiqi; Robertino Mera-Giler; Xiaohong Hu; Karen W Hoover; Norma S Harris; Scott McCallister
Journal:  Clin Infect Dis       Date:  2020-12-15       Impact factor: 9.079

8.  Combinations of interventions to achieve a national HIV incidence reduction goal: insights from an agent-based model.

Authors:  Chaitra Gopalappa; Stephanie L Sansom; Paul G Farnham; Yao-Hsuan Chen
Journal:  AIDS       Date:  2017-11-28       Impact factor: 4.177

Review 9.  Technology-Delivered Intervention Strategies to Bolster HIV Testing.

Authors:  Romina A Romero; Jeffrey D Klausner; Lisa A Marsch; Sean D Young
Journal:  Curr HIV/AIDS Rep       Date:  2021-06-09       Impact factor: 5.071

10.  A Systematic Review and Meta-analysis to Estimate the Time from HIV Infection to Diagnosis for People with HIV.

Authors:  Semiu O Gbadamosi; Mary Jo Trepka; Rahel Dawit; Rime Jebai; Diana M Sheehan
Journal:  AIDS Rev       Date:  2022-03-01       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.